Fosun Pharma (02196.HK) Announces First Three Quarters Results: Net Profit Attributable to Parent 2.667 Billion Yuan, Up 5.71% YoY

Zhitong Finance APP News, Fosun Pharma (02196.HK) released its performance for the first three quarters of 2026. The Group achieved operating revenue of RMB 30.463 billion, a year-on-year increase of 3.64%; net profit attributable to shareholders of the listed company was RMB 2.667 billion, a year-on-year increase of 5.71%; basic earnings per share were RMB 1.01.